REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/09/2025
Back to search
Official data from USPTO
TGCA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
TGCA
ST13
US500000088422345Class
35, 41, 42
Filing
88422345
Registration
6072598
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
15
Latest update
06/10/2025
Classification
Registered
Trademark type
Word
Nice classes
35, 41, 42
Filing date
05/09/2019
Registration date
06/09/2020
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/09/2020
Last transaction
06/10/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
04/12/2019
First use in commerce
04/12/2019
Drawing code
4
Owner type
16
Owner location
Chapel Hill, NC
Examiner
KHOURI, SANI
Law office
M10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Therapeutic Genetics Consulting Associates LLC
Representatives
Devon E. White Wyrick Robbins Yates & Ponton LLP
Technical classification
Nice Classes
Class 35Class 41Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business management and consultation services in the field of specialty pharmacypharmaceutical manufacturersgenetic medicine and therapiesRNA based therapeuticscell therapies and gene-modified cell therapiespharmacy benefit managersphysicianshealth systems; Business risk managementconsulting and information services in the field of specialty pharmacypharmaceutical manufacturersgenetic medicine and therapiesRNA based therapeuticscell therapies and gene-modified cell therapiespharmacy benefit managersphysicianshealth systems; Business marketing consulting services; Business consulting services in the field of pharmaceutical and drug development
Class 41
Educational services in the field of specialty pharmacygenetic medicine and therapiesRNA based therapeuticscell therapies and gene-modified cell therapiespharmacogeneticspharmacy payer and reimbursementtherapeutic patient care risk analysis and managementpharmacy manufacturingin face-to-face and web-based coursesseminarsworkshops and training sessions; Educational services in the field new therapies and risk management for patient care in face-to-face and web-based coursesseminarsworkshops and training sessions; Educational services provided to stakeholdersPharmaceutical ManufacturersPayersPBMSHealth SystemsIDN'sPhysiciansSpecialty Pharmaciespatients and in the field of genetic therapies and pharmacogenetics in face-to-face and web-based coursesseminarsworkshops and training sessions; Providing an educational website portal for providers and patients featuring non-downloadable videos in the field of specialty pharmaciespharmaceutical manufacturersgenetic medicine and therapiesRNA based therapeuticscell therapies and gene-modified cell therapiespharmacy benefit managersphysicianshealth systems; Providing an educational website portal for providers and patients featuring non-downloadable videos in the field of new therapies and risk management; Research servicesthe design and development of data collection methodologiesthe collection of datathe reporting of results for developing training systems and learning methodologies for others
Class 42
Research servicesproviding customized studies of data and researchmedical and scientific research services; Research servicesthe design and development of data collection methodologiesthe collection of datathe reporting of results for medical research and scientific research purposes; Providing research and support services for the management and reporting of outcomes of therapiesfor medical research and scientific research purposes
Publications
History of USPTO decisions and trademark events.
15 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/09/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/24/2020
PUBO
PUBLISHED FOR OPPOSITION
03/24/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/04/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/18/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/29/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/29/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/29/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/31/2019
GNRT
NON-FINAL ACTION E-MAILED
07/31/2019
CNRT
NON-FINAL ACTION WRITTEN
07/31/2019
DOCK
ASSIGNED TO EXAMINER
07/25/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/23/2019
NWAP
NEW APPLICATION ENTERED
05/13/2019
Continuous trademark protection
Get notified about every new filing that threatens TGCA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.